Elaborate testing is necessary to ensure the stability and functionality of today's drug-delivery systems
The pharma industry needs to go farther in adapting to new marketplace realities
A 'performance curve' chart for containers could simplify the design process
Modernized packaging technologies can change the drug-distribution dynamic - and improve overall healthcare
With a number of vaccine trials progressing globally, recent data loss and quality control errors have raised the importance of ensuring effective data systems in this effort
Hubs and other patient services need to stress the personal
While the pharma industry is growing more dependent on companion diagnostics, test developers face an uncertain business model
Both pharmacological and economic factors drive the decision to use these technologies
Given the profound changes in the pharmaceutical commercial model, sales and marketing must deliver integrated customer experiences across channels and adapt through real-time insights
Your serialization systems aren’t as interoperable as you might think
Conventional training of sales forces is being complemented by executive-level training for corporate compliance
Ultimately, supply chain integrity should include both temperature control and security against theft or diversion
Overestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
A changing role for hubs in collecting critical data, raising adherence
New technologies are creating a powerful link between patients and healthcare providers. This Connected Health World has implications for pharmaceutical business practices
European experience to date indicates a changing perspective on biosimilar pricing
Longitudinal patient-level data answer pressing questions about patient safety, outcomes and medication acceptance
With today's pharmacy landscape shaken by unprecedented and wider disruption to healthcare support and delivery, community and independent entities strive to remain an integral cog in the mix.
Digital systems are changing the economics and functionality of scheduling and production of printed packaging
Industry and FDA can—and must—do more to protect global pharmaceutical supply chains
‘Class of Trade’ is a murky element of contracts and channel analytics that can have important legal implications
How they embrace collaboration will be key to the battle against RSV.
The current economic downturn may fuel the creation of new, more sustainable business models
Usually associated with manufacturing or laboratory processes, quality systems can improve post-marketing compliance efforts